Skip to main content.

Barbara Feder Ostrov's Health Journalism Blog

Veteran health journalist Barbara Feder Ostrov blogs about all things health journalism-related, in particular providing tips for reporters covering health policy, health reform, public health, community health, local health issues, access to care, health insurance, SCHIP, Medicaid and Medicare.

Picture of Tammy Worth

The surprisingly intense pushback against a proposed ban on school bake sales in Mass. is just the latest example of how hard it is for schools to improve their nutrition — and kids' health. 

Picture of Tammy Worth

Psychologist and mom Polly Palumbo didn't just get mad when she read irresponsible media coverage of children's health issues — she started debunking it in her blog, Momma Data.

Picture of Barbara Feder Ostrov

What happens when the profit incentive takes over dental care for underserved schoolkids?

Picture of Barbara Feder Ostrov

Why focusing on obesity is a gift for the food industry.

Picture of Barbara Feder Ostrov

Why the childhood obesity prevention movement is still struggling.

Picture of Barbara Feder Ostrov

Why is the Obama administration still putting taxpayer dollars into abstinence-only sex education? One journalist examines the issue.

Picture of Barbara Feder Ostrov

In a controversial JAMA essay, Dr. Paul Offit says taxpayers are spending millions on federal research into misguided alternative medicine treatments. Why are we still doing it?

Picture of Barbara Feder Ostrov

How do you sort through the cacophony of health conversations taking place on Twitter? Healthcare hashtags can help.

Picture of Barbara Feder Ostrov

From nocturnists to Medicaid babies, a sampling of story ideas from the 2012 AHCJ health journalism conference in Atlanta.

Picture of Barbara Feder Ostrov

You’d hope organ donors would be dead beyond any doubt when their organs are harvested, but in his new book, Dick Teresi argues that they may not be dead enough.

Pages

Announcements

It's been a couple weeks of big headlines touting surprisingly high levels of vaccine efficacy from ongoing trials by Pfizer and Moderna. But huge logistical and ethical challenges remain in getting large swathes of the country vaccinated. Which groups should get their shots first? Join us for our next webinar on Nov. 24 (1-2 p.m. ET), when we’ll take an updated look at those hurdles, and discuss how you can translate this massive and urgent story for audiences in the weeks and months to come. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth